EP 2026654 A2 20090225 - MACROPHAGE MIGRATION INHIBITORY FACTOR ANTAGONISTS AND METHODS OF USING SAME
Title (en)
MACROPHAGE MIGRATION INHIBITORY FACTOR ANTAGONISTS AND METHODS OF USING SAME
Title (de)
MAKROPHAGEN-MIGRATIONS-HEMMFAKTOR-ANTAGONISTEN UND VERWENDUNGSVERFAHREN DAFÜR
Title (fr)
ANTAGONISTES DU FACTEUR D'INHIBITION DE LA MIGRATION DES MACROPHAGES ET LEURS PROCÉDÉS D'UTILISATION
Publication
Application
Priority
- US 2007069672 W 20070524
- US 80867906 P 20060526
Abstract (en)
[origin: WO2007140263A2] Methods of inhibiting one or more biological activities of Macrophage migration inhibitory factor (MIF) polypeptides are provided using an MIF inhibitory compound. The methods include therapeutic methods for treating cancers and inflammatory diseases.
IPC 8 full level
A01N 43/54 (2006.01); A61K 31/513 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/513 (2013.01 - EP US); A61P 3/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007140263 A2 20071206; WO 2007140263 A3 20081120; WO 2007140263 A9 20080403; AU 2007267593 A1 20071206; AU 2007267593 B2 20130404; CA 2653733 A1 20071206; CN 101528039 A 20090909; EP 2026654 A2 20090225; EP 2026654 A4 20130717; JP 2009541214 A 20091126; US 2011009412 A1 20110113; US 8999984 B2 20150407
DOCDB simple family (application)
US 2007069672 W 20070524; AU 2007267593 A 20070524; CA 2653733 A 20070524; CN 200780028307 A 20070524; EP 07811937 A 20070524; JP 2009513395 A 20070524; US 30178307 A 20070524